Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Expert Opinion on Investigational Drugs
|
July 5, 2005
The link between inflammatory disease and patterns of leukocyte recruitment
W Newman, C K Mirabelli
The American Journal of Medicine
|
December 30, 1983
Molecular mechanisms of action of auranofin and other gold complexes as related to their biologic activities
S T Crooke, C K Mirabelli
Cancer Chemotherapy and Pharmacology
|
January 1, 1981
Comparison of the response of synchronized HeLa cells to talisomycin and bleomycin
C K Mirabelli, S T Crooke
Immunopharmacology
|
December 1, 1985
Generation of suppressor cells in normal rats by treatment with spirogermanium, a novel heterocyclic anticancer drug
A M Badger, C K Mirabelli, M DiMartino
Biochemistry
|
January 18, 1983
Role of deoxyribonucleic acid topology in altering the site/sequence specificity of cleavage of deoxyribonucleic acid by bleomycin and talisomycin
C K Mirabelli, C H Huang, S T Crooke
Seminars in Arthritis and Rheumatism
|
August 1, 1987
The cellular pharmacology of auranofin
R M Snyder, C K Mirabelli, S T Crooke
Biochemical Pharmacology
|
March 1, 1987
Cellular interactions of auranofin and a related gold complex with RAW 264.7 macrophages
R M Snyder, C K Mirabelli, S T Crooke
Cancer Research
|
November 1, 1980
Comparison of DNA damage and single- and double-strand breakage activities on PM-2 DNA by talisomycin and bleomycin analogs
C K Mirabelli, C H Huang, S T Crooke
Biochemical Pharmacology
|
March 15, 1986
Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactions
R M Snyder, C K Mirabelli, S T Crooke
The Journal of Rheumatology
|
April 1, 1984
Effect of gold compounds on phorbol myristic acetate (PMA) activated superoxide (O2-) production by mouse peritoneal macrophages
C P Sung, C K Mirabelli, A M Badger
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Expert Opinion on Investigational Drugs
|
July 5, 2005
The link between inflammatory disease and patterns of leukocyte recruitment
W Newman, C K Mirabelli
The American Journal of Medicine
|
December 30, 1983
Molecular mechanisms of action of auranofin and other gold complexes as related to their biologic activities
S T Crooke, C K Mirabelli
Cancer Chemotherapy and Pharmacology
|
January 1, 1981
Comparison of the response of synchronized HeLa cells to talisomycin and bleomycin
C K Mirabelli, S T Crooke
Immunopharmacology
|
December 1, 1985
Generation of suppressor cells in normal rats by treatment with spirogermanium, a novel heterocyclic anticancer drug
A M Badger, C K Mirabelli, M DiMartino
Biochemistry
|
January 18, 1983
Role of deoxyribonucleic acid topology in altering the site/sequence specificity of cleavage of deoxyribonucleic acid by bleomycin and talisomycin
C K Mirabelli, C H Huang, S T Crooke
Seminars in Arthritis and Rheumatism
|
August 1, 1987
The cellular pharmacology of auranofin
R M Snyder, C K Mirabelli, S T Crooke
Biochemical Pharmacology
|
March 1, 1987
Cellular interactions of auranofin and a related gold complex with RAW 264.7 macrophages
R M Snyder, C K Mirabelli, S T Crooke
Cancer Research
|
November 1, 1980
Comparison of DNA damage and single- and double-strand breakage activities on PM-2 DNA by talisomycin and bleomycin analogs
C K Mirabelli, C H Huang, S T Crooke
Biochemical Pharmacology
|
March 15, 1986
Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactions
R M Snyder, C K Mirabelli, S T Crooke
The Journal of Rheumatology
|
April 1, 1984
Effect of gold compounds on phorbol myristic acetate (PMA) activated superoxide (O2-) production by mouse peritoneal macrophages
C P Sung, C K Mirabelli, A M Badger
Page
of 8